The Inhibitory Effects of Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide on Osteoclast Formation Are Associated with Upregulation of Osteoprotegerin and Downregulation of RANKL and RANK
- 29 April 2000
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 271 (1), 158-163
- https://doi.org/10.1006/bbrc.2000.2599
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Neuro-hormonal control of bone metabolism:Regulatory Peptides, 1999
- Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand FamiliesEndocrine Reviews, 1999
- OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesisNature, 1999
- RANK Is the Essential Signaling Receptor for Osteoclast Differentiation Factor in OsteoclastogenesisBiochemical and Biophysical Research Communications, 1998
- Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKLProceedings of the National Academy of Sciences, 1998
- A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell functionNature, 1997
- TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T CellsJournal of Biological Chemistry, 1997
- Neuroendocrine regulation of cyclic AMP formation in osteoblastic cell lines (UMR-106–01, ROS 17/2.8, MC3T3-E1, and Saos-2) and primary bone cellsJournal of Bone and Mineral Research, 1992
- Functional Receptors for Vasoactive Intestinal Peptide on Human Osteosarcoma Cells*Endocrinology, 1984
- Vasoactive Intestinal Peptide Stimulates Bone Resorption via a Cyclic Adenosine 3′,5′-Monophosphate-Dependent Mechanism*Endocrinology, 1983